Melanie Sloan1, Caroline Gordon2, Rupert Harwood3, Elliott Lever4, Chris Wincup4, Michael Bosley3, James Brimicombe1, Mark Pilling1, Stephen Sutton1, Lynn Holloway3, David D'Cruz5. 1. Department of Public Health and Primary Care, School of Clinical Medicine, University of Cambridge, Cambridge. 2. Rheumatology Research Group, Institute of Inflammation and Ageing, College of Medical and Dental Science, University of Birmingham, Birmingham. 3. Patient and Public Involvement in Lupus Research Group, Institute of Public Health, University of Cambridge, Cambridge. 4. Rheumatology Department, University College London Hospital. 5. Louise Coote Lupus Unit, Guys' and St Thomas' NHS foundation Trust, London, UK.
Abstract
OBJECTIVE: The aim was to explore the self-reported impact of the COVID-19 pandemic on changes to care and behaviour in UK patients with systemic autoimmune rheumatic diseases, to help ensure that patient experiences are considered in future pandemic planning. METHODS: This was a longitudinal mixed methods study, with a cohort completing baseline surveys in March 2020 and follow-up surveys in June 2020 (n = 111), combined with thematic analysis of the LUPUS UK forum and participant interviews (n = 28). RESULTS: Cancellations of routine care and difficulties in accessing medical support contributed to some participants deteriorating physically, including reports of hospitalizations. The majority of participants reported that fear of COVID-19 and disruptions to their medical care had also adversely impacted their mental health. Feeling medically supported during the pandemic was correlated with multiple measures of mental health and perceptions of care, including the Warwick-Edinburgh mental well-being score (r = 0.44, P = 0.01). Five themes were identified: detrimental reduction in care; disparities in contact and communication (medical security vs abandonment sub-theme); perceived and actual endangerment; the perfect storm of reduced clinician ability to help and increased patient reticence to seek help; and identifying the patients most vulnerable to reduced medical care. CONCLUSION: The diversion of resources away from chronic disease care was perceived by many participants to have caused adverse outcomes. Fear about increased vulnerability to COVID-19 was high, contributing to health-care-avoidant behaviours. This study also highlights the influence of clinician accessibility and patients feeling medically supported on multiple measures of physical and mental health.
OBJECTIVE: The aim was to explore the self-reported impact of the COVID-19 pandemic on changes to care and behaviour in UK patients with systemic autoimmune rheumatic diseases, to help ensure that patient experiences are considered in future pandemic planning. METHODS: This was a longitudinal mixed methods study, with a cohort completing baseline surveys in March 2020 and follow-up surveys in June 2020 (n = 111), combined with thematic analysis of the LUPUS UK forum and participant interviews (n = 28). RESULTS: Cancellations of routine care and difficulties in accessing medical support contributed to some participants deteriorating physically, including reports of hospitalizations. The majority of participants reported that fear of COVID-19 and disruptions to their medical care had also adversely impacted their mental health. Feeling medically supported during the pandemic was correlated with multiple measures of mental health and perceptions of care, including the Warwick-Edinburgh mental well-being score (r = 0.44, P = 0.01). Five themes were identified: detrimental reduction in care; disparities in contact and communication (medical security vs abandonment sub-theme); perceived and actual endangerment; the perfect storm of reduced clinician ability to help and increased patient reticence to seek help; and identifying the patients most vulnerable to reduced medical care. CONCLUSION: The diversion of resources away from chronic disease care was perceived by many participants to have caused adverse outcomes. Fear about increased vulnerability to COVID-19 was high, contributing to health-care-avoidant behaviours. This study also highlights the influence of clinician accessibility and patients feeling medically supported on multiple measures of physical and mental health.
Authors: Caroline Gordon; Maame-Boatemaa Amissah-Arthur; Mary Gayed; Sue Brown; Ian N Bruce; David D'Cruz; Benjamin Empson; Bridget Griffiths; David Jayne; Munther Khamashta; Liz Lightstone; Peter Norton; Yvonne Norton; Karen Schreiber; David Isenberg Journal: Rheumatology (Oxford) Date: 2018-01-01 Impact factor: 7.580
Authors: Vasco C Romão; Inês Cordeiro; Carla Macieira; Filipa Oliveira-Ramos; José Carlos Romeu; Carlos Miranda Rosa; Maria João Saavedra; Fernando Saraiva; Elsa Vieira-Sousa; João Eurico Fonseca Journal: RMD Open Date: 2020-06
Authors: Ruth Tennant; Louise Hiller; Ruth Fishwick; Stephen Platt; Stephen Joseph; Scott Weich; Jane Parkinson; Jenny Secker; Sarah Stewart-Brown Journal: Health Qual Life Outcomes Date: 2007-11-27 Impact factor: 3.186
Authors: Emma Dures; Susan Bridgewater; Bryan Abbott; Jo Adams; Alice Berry; Lance M McCracken; Siobhan Creanor; Sarah Hewlett; Joe Lomax; Mwidimi Ndosi; Joanna Thorn; Marie Urban; Paul Ewings Journal: BMJ Open Date: 2022-07-18 Impact factor: 3.006
Authors: Melanie Sloan; Caroline Gordon; Elliott Lever; Rupert Harwood; Michael A Bosley; Mark Pilling; James Brimicombe; Felix Naughton; Moira Blane; Chanpreet Walia; David D'Cruz Journal: Rheumatol Adv Pract Date: 2021-01-21
Authors: LaKrista Morton; Kevin Stelfox; Marcus Beasley; Gareth T Jones; Gary J Macfarlane; Peter Murchie; John Paton; Rosemary Hollick Journal: Rheumatol Adv Pract Date: 2022-02-16
Authors: Ho So; Evelyn Chow; Isaac T Cheng; Sze-Lok Lau; Tena K Li; Cheuk-Chun Szeto; Lai-Shan Tam Journal: Lupus Date: 2022-03-07 Impact factor: 2.911
Authors: Mitchell L Ramsey; Arsheya Patel; Lindsay A Sobotka; Woobeen Lim; Robert B Kirkpatrick; Samuel Han; Phil A Hart; Somashekar G Krishna; Luis F Lara; Peter J Lee; Darwin L Conwell; Georgios I Papachristou Journal: Pancreas Date: 2022-07-16 Impact factor: 3.243